Onyx BiotecNSE:ONYX +2.08%13 Market Cap is ₹755.2 Mil as of Jul. 02, 2026. GuruFocus rates NSE:ONYX with a GF Score™ of 13/100. The stock has 6 warning signs investors should review. Among 869 Medical Devices & Instruments companies, Onyx Biotec ranks worse than 87.46% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Onyx Biotec's share price for the quarter that ended in Mar. 2026 was ₹34. Onyx Biotec's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 18.1 Mil. Therefore, Onyx Biotec's market cap for the quarter that ended in Mar. 2026 was ₹613.8 Mil.
Onyx Biotec's quarterly market cap
declined
from Mar. 2025 (₹1,051.7 Mil) to Sep. 2025 (₹774.4 Mil) and
declined
from Sep. 2025 (₹774.4 Mil) to Mar. 2026 (₹613.8 Mil).
Onyx Biotec's annual market cap
increased
from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹1,051.7 Mil) but then
declined
from Mar. 2025 (₹1,051.7 Mil) to Mar. 2026 (₹607.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Onyx Biotec's Enterprise Value for Today is ₹866.5 Mil.
Onyx Biotec (NSE:ONYX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Onyx Biotec Market Cap Related Terms
Onyx Biotec Market Cap Historical Data
* Premium members only.
The historical data trend for Onyx Biotec's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ONYX vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, Onyx Biotec's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Onyx Biotec Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Onyx Biotec's Market Cap distribution charts can be found below:
* The bar in red indicates where Onyx Biotec's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Onyx Biotec's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Onyx Biotec (NSE:ONYX) has a Market Cap of ₹755.2 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Onyx Biotec and its competitors. According to the industry distribution chart, Onyx Biotec ranks #760 out of 869 companies in the Medical Devices & Instruments industry, placing it in the top 87.5%.
Is Onyx Biotec's Market Cap too high?
Onyx Biotec's current Market Cap is ₹755.2 Mil. Based on the distribution chart, Onyx Biotec ranks #760 out of 869 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Onyx Biotec has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Onyx Biotec's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Onyx Biotec ranks #760 out of 869 companies for Market Cap. This places Onyx Biotec in the lower half of its industry. The industry median Market Cap is 119.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 119.28, based on 869 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Onyx Biotec and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 119.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onyx Biotec's current Market Cap is ₹755.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onyx Biotec stock overvalued right now?
Onyx Biotec (NSE:ONYX) has a current Market Cap of ₹755.2 Mil. The current Market Cap is ₹755.2 Mil. Onyx Biotec's overall GF Score™ is 13/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Onyx Biotec (NSE:ONYX), the current Market Cap is ₹755.2 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Onyx Biotec Ltd is engaged in healthcare segment and offering Sterile Pharmaceutical products ,and acts as a pharmaceutical contract manufacturer. It offering products such as Sterile Water for Injections, Dry Powder Injections and Dry Syrup for India and overseas. Key revenue is generated from Sterile Water for Injections .
13GF Score
Get the complete analysis for NSE:ONYX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ONYX has been successfully added to your 